An internationally recognized testing institution, assisting enterprises in achieving technological advancement.
ZHONGXI Testing has obtained inspection qualification certifications from multiple countries and regions worldwide. We possess a senior testing team and advanced testing methods, providing independent, impartial, and professional third-party verification services for global carbon projects.
Certified by multiple international standards such as CNAS, VCS, and GS, with reports universally applicable worldwide.
Covering 140+ countries and regions, it supports on-site detection and remote verification in multiple languages.
Adopt standard experimental methods to ensure accurate and reliable data.
Diphenyl oxalate (DPO) is a key intermediate in the synthesis of fluorescent whitening agents, pharmaceuticals, and specialty polymers, as well as a crucial precursor in chemiluminescent reactions. Its high purity and stability are paramount, as trace impurities – such as phenyl salicylate, phenol, or oxalic acid derivatives – can severely affect reaction yields, optical properties, and product safety. Customers seeking diphenyl oxalate testing typically aim to verify raw material quality, monitor process impurities, comply with regulatory limits (e.g., residual solvents, heavy metals), or troubleshoot batch failures. Routine melting point or simple HPLC‑UV checks often lack the sensitivity and selectivity needed to detect low‑level degradation products or isomeric contaminants. Our diphenyl oxalate testing service delivers a comprehensive, multi‑technique analytical approach that combines high‑resolution chromatography, mass spectrometry, thermal analysis, and stability‑indicating methods. We provide definitive identification and precise quantification of diphenyl oxalate and its related substances – down to parts‑per‑million (ppm) and even sub‑ppm levels – using validated protocols tailored to your specific application, whether for R&D, quality control, or regulatory submission.

Our clients include pharmaceutical and agrochemical companies using DPO as a building block, chemical manufacturers producing DPO on an industrial scale, contract research organisations developing new synthetic routes, and regulatory compliance laboratories requiring independent verification of product specifications. Common challenges include: detection of phenol (a genotoxic impurity) at trace levels, separation of DPO from its hydrolytic degradation product (phenyl hydrogen oxalate), quantification of residual solvents (e.g., pyridine, toluene) used in synthesis, and assessment of thermal stability during storage or melt‑processing. Our service addresses these by employing state‑of‑the‑art separation methods (UHPLC‑PDA‑MS, GC‑MS, and ion chromatography), stability‑indicating assay development, and forced degradation studies to identify and quantify all potential impurities, ensuring that your product meets the strictest quality standards.
We adopt a systematic, risk‑based approach that covers all critical quality attributes (CQAs) of diphenyl oxalate, from identity confirmation to impurity profiling and stability assessment. All methods are developed and validated in accordance with ICH Q2(R1) and USP <1225> guidelines, with flexibility for custom requirements.
We use ultra‑high‑performance liquid chromatography (UHPLC) coupled with photodiode array (PDA) and high‑resolution mass spectrometry (HRMS) for the primary assay of diphenyl oxalate. Our optimised reversed‑phase method ensures baseline separation of DPO from its synthetic intermediates and degradation products. We quantify DPO against a certified reference standard (or our internally validated secondary standard) and provide chromatographic purity (area%) and assay (wt%) with full statistical confidence intervals. For definitive identification, we use accurate mass MS/MS to confirm molecular formula (C₁₄H₁₀O₄, [M+H]⁺ = 243.0652) and characteristic fragmentation patterns, eliminating any ambiguity from co‑eluting impurities.
Phenol is a critical impurity due to its toxicity and its potential to affect subsequent reactions. We have developed a sensitive UHPLC‑MS/MS method using a polar‑embedded stationary phase and negative‑ion detection to quantify phenol down to 5 ppm in diphenyl oxalate bulk material. For other process‑related impurities – such as phenyl salicylate, diphenyl carbonate, and oxalic acid monoesters – we employ a gradient UHPLC‑PDA‑MS method with a comprehensive impurity database. We also provide ion chromatography (IC) with suppressed conductivity to detect ionic impurities (chloride, sulfate, nitrate) that may originate from workup procedures. All impurity results are reported with respect to the ICH Q3A/B thresholds for residual and degradant impurities.
Synthesis of diphenyl oxalate often involves solvents such as pyridine, toluene, dichloromethane, or tetrahydrofuran. We perform headspace gas chromatography (HS‑GC) coupled with mass spectrometry (MS) and flame ionisation detection (FID) in parallel to quantify all Class 1, 2, and 3 residual solvents per ICH Q3C guidelines. Our validated method achieves detection limits well below the permitted daily exposure (PDE) limits, typically in the 1–50 ppm range. We provide a full residual solvent profile, including any unknown volatile organic compounds (VOCs) detected by full‑scan MS.
Diphenyl oxalate can undergo hydrolysis, transesterification, or thermal decomposition during storage or processing. We use Thermogravimetric Analysis (TGA) under nitrogen and air atmospheres to determine decomposition onset temperature, and differential scanning calorimetry (DSC) to measure melting point and detect any polymorphic transitions or exothermic events. For accelerated stability studies, we conduct forced degradation under heat (60–80 °C), humidity (75% RH), and light (ICH Q1B), followed by UHPLC‑PDA‑MS to identify and quantify degradation products. We provide a stability‑indicating HPLC method that separates DPO from at least six degradation peaks, enabling you to assign shelf life and storage conditions.
To comply with ICH Q3D or USP <232> standards, we perform inductively coupled plasma‑mass spectrometry (ICP‑MS) for the quantitative determination of Class 1, 2A, and 3 elemental impurities, including arsenic, cadmium, lead, mercury, and chromium. Our acid‑digestion protocol ensures complete sample mineralisation, and we achieve sub‑ppb detection limits. We also screen for residual palladium or other catalyst metals if your synthesis uses transition‑metal catalysts.
Moisture content significantly affects the stability of diphenyl oxalate, as it promotes hydrolysis. We determine water content using coulometric Karl Fischer titration with a specialized oven sample preparation to release bound water, providing results accurate to ± 0.02%.
For full structure elucidation and batch‑to‑batch consistency, we perform ¹H NMR, ¹³C NMR, and 2D‑COSY/HSQC on a 600 MHz instrument, verifying the characteristic ester carbonyl, phenyl, and bridging signals. FT‑IR (ATR mode) is used to confirm the presence of C=O ester stretching (∼1765 cm⁻¹) and aromatic C‑H bending, providing an additional fingerprint for identity checks.
For clients with novel formulations or matrix‑specific challenges (e.g., DPO in polymer blends or formulation intermediates), we offer full method development and validation services, including forced degradation studies, limit of detection (LOD) and quantification (LOQ) determination, linearity, accuracy, precision, and robustness testing. We can also transfer validated methods to your in‑house QC labs.
Our laboratory is equipped with a fully integrated analytical platform that includes UHPLC‑HRMS‑MS, GC‑MS with headspace and thermal desorption, IC, ICP‑MS, TGA‑DSC, and 600 MHz NMR – all under one roof, ensuring seamless data correlation and rapid turnaround. We have developed dedicated sample preparation protocols for diphenyl oxalate that minimise hydrolysis during handling, and we operate under inert‑atmosphere gloveboxes when required.
Our team comprises organic chemists and analytical methodologists with extensive experience in ester chemistry and impurity profiling. We do not simply provide test results; we offer interpretive insight – for example, linking the presence of certain impurities to specific process steps (e.g., incomplete transesterification or solvent residue from recrystallisation), and recommending corrective actions. We also provide comparative analysis against your reference material or competitor products, giving you a competitive quality advantage.
All testing follows strict GMP/GLP principles and is documented in accordance with ICH and FDA guidelines. Our reports include measurement uncertainty and full traceability to NIST‑traceable standards. We also offer rapid emergency testing for batch release or troubleshooting, with results typically within 48–72 hours for priority projects.
Your final report will be a comprehensive dossier, structured as follows:
Section 1 – Identity and purity: UHPLC chromatograms (DAD and MS), assay (wt%), chromatographic purity (area%), and identity confirmation (MS, NMR, FT‑IR).
Section 2 – Impurity profile: Quantitative results for all specified and unspecified impurities (phenol, related esters, organic acids, etc.) with comparison to specification limits.
Section 3 – Residual solvents: Complete HS‑GC‑MS/FID results for Class 1, 2, and 3 solvents, with pass/fail against ICH limits.
Section 4 – Elemental impurities: ICP‑MS data for metals, with risk‑based assessment per ICH Q3D.
Section 5 – Thermal and stability data: DSC and TGA curves, forced degradation profiles, and recommended storage conditions.
Section 6 – Moisture content: Karl Fischer results.
Section 7 – Summary and recommendations: Overall quality rating, any out‑of‑specification findings, and proposed corrective actions.
All raw data – chromatograms, spectra, thermograms, and calibration curves – are provided in standard digital formats (AIA, JCAMP, CSV) for your own evaluation.
Our diphenyl oxalate testing serves pharmaceutical excipient and API manufacturers, specialty chemical producers (optical brighteners, chemiluminescent reagents), polymer additive suppliers, and environmental monitoring laboratories testing for DPO as a contaminant. We also support regulatory submissions (NDA, ANDA, DMF) with full analytical method validation and stability data packages.
Engaging our service is straightforward:
1. Consultation: We discuss your product specification, intended use, and any specific impurity concerns or regulatory requirements.
2. Customised proposal: We design a test matrix with modular options and provide a fixed price and timeline – typically 5–7 working days for a complete profile, with expedited options.
3. Sample submission: We supply detailed instructions for sampling, packaging (e.g., amber glass, desiccated), and shipping.
4. Analysis and review: We perform the tests and share interim results for your feedback.
5. Final report and interpretive session: You receive the comprehensive report, followed by a 45‑minute virtual meeting to discuss findings and recommend actions.
We guarantee confidentiality under a standard NDA and can accommodate both single‑batch and routine monitoring programmes with volume discounts.
The purity and stability of diphenyl oxalate are essential for its successful application in sensitive chemical processes. Our diphenyl oxalate testing service provides the analytical depth, regulatory compliance, and scientific interpretation needed to confidently manage your product quality. With state‑of‑the‑art instrumentation, experienced chemists, and a commitment to data integrity, we deliver the clarity and assurance you require for R&D, quality control, and regulatory success.
Contact our analytical specialists today to discuss your project and receive a tailored proposal. Let us help you achieve uncompromised quality for your diphenyl oxalate.
Beijing ZKGX Institute of Science and Technology , combining applied research with technological transformation. It has evolved into a comprehensive research institute characterized primarily by a "task-driven disciplines" approach. Approved by relevant authorities, it currently operates as a third-party analytical testing technical service provider. Its affiliated laboratory facilities hold certifications including CMA and CNAS, possess an Experimental Animal Use License, and have achieved triple certification for ISO9001 Quality Management System, ISO14001 Environmental Management System, and ISO45001 Occupational Health and Safety Management System.